J Neurochem (2003) 87(5):113744
These women are losing weight and then going on to conceive. A new therapeutic option There is growing interest in GLP-1 receptor agonist use for improving fertility odds, especially for women with obesity and/or polycystic ovary syndrome
Realistically, many users experience: 510 pounds lost in the first month, primarily due to reduced appetite and calorie intake 1020% total body weight loss over 612 months (depending on the drug) Slower, steady progress as the body adjusts to the medication Sustained weight loss is often achievable with continued use of the medication after reaching your goal weight To shed light on whats truly typical, we asked a provider with firsthand experience
But the experience of using these medications isnt always straightforward
Employers are absorbing GLP-1 costs in real time while the actuarial savings, reduced cardiac events, fewer joint replacements, lower diabetes incidence, materialize over five to ten The way Im researching this rn because I snack a little too much Join the conversation